Phillipus Putter

Phillipus Putter is an Associate in the Firm's Intellectual Property group based in London. His primary practice area is Patent Law, and he focuses primarily on Life Sciences patent litigation.

He has represented clients in complex multi-jurisdictional disputes before the High Court and Court of Appeal. He also advises clients on a wide range of regulatory matters, particularly in the pharmaceutical and medical device sectors. His experience encompasses orphan drugs, biologics and other advanced therapy medicinal products, and he has worked with clients on a range of issues from marketing authorisations and SPCs to clinical trials.

He contributed to several chapters of the 2023 Guide to EU and UK Pharmaceuticals Regulatory Law (8th Ed. Wolters Kluwer) and was involved in the upcoming 2025 edition.

Before entering the legal profession, he spent five years in pre-clinical research at the University of Oxford, a background which affords a distinctive advantage for life sciences and healthcare clients. His academic work focused on regenerative approaches for neurological injury models such as haemorrhagic stroke and traumatic brain injury, and practically, he spent a lot of time culturing stem cells in three-dimensional matrices and developing novel biomimetic materials to treat brain and spine injuries.

His academic experience provides not only specific insights into scientific research methods but also a broader foundation that facilitates meaningful engagement with complex technical subject matter, allowing him to align legal strategies with the realities of scientific research and ultimately the commercialisation of both innovative and generic products.